-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, the Insight database revealed that Microchip Bio-Sioroni Capsules has launched a Phase III clinical trial for the treatment of small cell lung cancer that has progressed or recurred after a 2-line system of chemotherapy.
Sioroni is a new chemical structure with global patent protection independently designed and developed by Microchip.
In the previous clinical trials of Sioroni, compared with historical control data, for SCLC patients who failed multi-line therapy, his single-agent therapy achieved very positive results.
At present, according to the Insight database, Sioroni has carried out 8 clinical trials, with indications covering ovarian cancer, liver cancer, breast cancer, lymphoma, and other neuroendocrine tumors.
Source: Insight database (http://db.
Source: Insight database (http://db.
dxy.
cn/v5/)